Spots Global Cancer Trial Database for locally advanced sarcoma

Every month we try and update this database with for locally advanced sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors	NCT04771520	Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Mela... Metastatic Prim... Metastatic Sarc... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Prognostic Stag... Prognostic Stag... Stage IIIC Colo... Stage IIIC Lung... Stage IV Colore... Stage IV Lung C... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color...	Avapritinib	18 Years -	M.D. Anderson Cancer Center
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas	NCT01106872	Sarcoma Soft Tissue Sar... Locally Advance... Unresectable Sa... Metastatic Sarc...	Bevacizumab, Ge...	18 Years - 99 Years	University of Iowa
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)	NCT04595747	Locally Advance... Locally Advance... Metastatic Gast... Metastatic Sarc... Stage III Gastr... Stage III Small... Stage IV Gastri... Stage IV Small ...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Positron Emissi... Rogaratinib	18 Years -	National Cancer Institute (NCI)
Cemiplimab for Secondary Angiosarcomas	NCT04873375	Secondary Angio... Locally Advance... Metastasis	Cemiplimab	18 Years -	Radboud University Medical Center
Cemiplimab for Secondary Angiosarcomas	NCT04873375	Secondary Angio... Locally Advance... Metastasis	Cemiplimab	18 Years -	Radboud University Medical Center
Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy	NCT02732015	Locally Advance...	Dexamethasone Doxorubicin Fosaprepitant D... Ifosfamide Laboratory Biom... Mesna Ondansetron Questionnaire A... Rolapitant Hydr... Vincristine Sul...	18 Years - 65 Years	M.D. Anderson Cancer Center
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas	NCT01106872	Sarcoma Soft Tissue Sar... Locally Advance... Unresectable Sa... Metastatic Sarc...	Bevacizumab, Ge...	18 Years - 99 Years	University of Iowa
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg	NCT04332874	Sarcoma Myxofibrosarcom... Undifferentiate... Alveolar Soft P...	Isolated Limb I... Pembrolizumab infusion of mel...	12 Years -	Memorial Sloan Kettering Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: